Skip to main content
. 2014 Aug 27;144(11):1734–1741. doi: 10.3945/jn.114.196709

TABLE 1.

Interaction of KCNJ1 rs2855798, SLC12A1 rs1531916, and intakes of calcium with colorectal adenoma risk: the Tennessee Colorectal Polyp Study1

Ge ne, SNP, and phase (all adenomas) Cases/controls MAF P-interaction2
n/n
KCNJ1, rs2855798
 I 728/756 0.20/0.20 0.006
 II 608/2135 0.20/0.20 0.03
 I and II 1336/2891 0.20/0.20 0.0001
KCNJ1, rs4529890
 I 727/757 0.15/0.16 0.01
 II 548/2063 0.14/0.14 0.06
 I and II 1275/2820 0.15/0.15 0.001
KCNJ1, rs4937378
 I 728/757 0.23/0.23 0.01
 II 547/2059 0.25/0.25 0.36
 I and II 1275/2816 0.24/0.24 0.02
KCNJ1, rs6590354
 I 728/757 0.04/0.04 0.02
 II
SLC12A1, rs1531916
 I 723/755 0.17/0.18 0.01
 II 547/2061 0.22/0.21 0.72
 I and II 1270/2816 0.19/0.19 0.08
1

KCNJ1, potassium inwardly-rectifying channel, subfamily J, member 1; MAF, minor allele frequency; SLC12A1, solute carrier family 12 member 1; SNP, single-nucleotide polymorphism.

2

Interactions between genetic polymorphism and calcium intake (continuous) by using a likelihood ratio test adjusting for age (continuous), sex, race (Caucasian, other), education (categorical), recruitment sites, BMI (categorical), smoking status (never, former, current), alcohol consumption status (never, former, current), physical activity (yes, no), and daily intakes of total energy and magnesium (continuous).